Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. (ZBH) is a global medical‑device company specialising in musculoskeletal healthcare — primarily joint replacement, spinal and dental solutions. With a market capitalisation around $20.3bn, it serves hospitals, surgeons and clinics through product sales, aftermarket services and implants. Key growth drivers include ageing populations, increasing demand for elective orthopaedic procedures and geographic expansion in emerging markets. Investors should watch procedure volumes, product mix, pricing pressure, merger and acquisition activity and reimbursement trends — these affect revenue and margins. The business is also exposed to regulatory, litigation and supply‑chain risks that can affect performance. Financially, margins can improve with scale and operational efficiency, but outcomes vary by cycle and region. This summary is educational and not personalised investment advice; shares can fall as well as rise. Consider your objectives and risk tolerance or consult a regulated adviser before acting.
Stock Performance Snapshot
Analyst Rating
Analysts suggest keeping Zimmer Biomet's stock as is, with room for potential growth.
Financial Health
Zimmer Biomet is performing well with strong profits and cash flow, indicating solid business health.
Dividend
Zimmer Biomet's low dividend yield of 1.1% suggests limited income potential for investors seeking dividends. If you invested $1000 you would be paid $11 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring ZBH
Healthcare Innovation: MedTech Giants Portfolio 2025
Growing demand for advanced healthcare in Africa highlights the global companies at the forefront of medical technology innovation. This theme offers exposure to US and EU-listed industry leaders in robotic surgery, diagnostic imaging, and other medical devices.
Published: September 22, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Aging population demand
An older population supports long‑term demand for joint replacements and related care, though procedure cycles and reimbursement can cause variability.
Global market exposure
Broad geographic presence can fuel growth as emerging markets adopt advanced care, but it also brings currency, regulatory and supply‑chain risks.
R&D and margins
Innovation and product mix can lift margins over time, yet investment cycles and competitive pricing pressure mean outcomes are uncertain.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
